e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Novel approach in diagnosis and treatment of pleural effusions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A prospective observational trial examining the value of T-cell interferon gamma release assays (IGRAs) in undiagnosed lymphocytic pleural effusions
H. Lamb, C. Hooper, P. Virgo, N. Noel, A. Kavidasan, M. Gompels, N. Maskell (Bristol, United Kingdom)
Source:
Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Session:
Novel approach in diagnosis and treatment of pleural effusions
Session type:
E-Communication Session
Number:
226
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Lamb, C. Hooper, P. Virgo, N. Noel, A. Kavidasan, M. Gompels, N. Maskell (Bristol, United Kingdom). A prospective observational trial examining the value of T-cell interferon gamma release assays (IGRAs) in undiagnosed lymphocytic pleural effusions. Eur Respir J 2010; 36: Suppl. 54, 226
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Lipoid pneumonia in infants: treatment with multiple bronchoalveolar lavages
Related content which might interest you:
Utility of a T-cell interferon-gamma release assay for the diagnosis of tuberculous serositis: A prospective study in Beijing, China
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
The clinical utility of interferon-γ release assay (IGRA) from pleural fluid in addition to IGRA from blood in patients with pleural effusion
Source: Annual Congress 2010 - Extrapulmonary tuberculosis
Year: 2010
Preliminary results of a prospective, multicentric randomized study comparing Interferon Gamma-1b (IFN-γ) and colchicine in the treatment of idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2003 - Interstitial lung diseases
Year: 2003
Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
What is the best test to detect latent tuberculosis infection in sarcoidosis patients? – Comparison between two commercially available interferon gamma release assays
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Diagnostic value of quantitative measurement of pleural fluid interferon-gamma (IFN–gamma) versus QuantiFERON-TB Gold in tube assays (QFT-IT) in blood, pleural fluid and isolated pleural fluid cells in tuberculous pleural effusion
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Utility of quantitative T-cell responses versus unstimulated interferon-gamma for the diagnosis of pleural tuberculosis
Source: Eur Respir J 2009; 34: 1118-1126
Year: 2009
Comparison of Interferon gamma-1b (IFN-γ)and colcicine in the treatment of Idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomised study
Source: Eur Respir J 2002; 20: Suppl. 38, 599s
Year: 2002
A prospective longitudinal study evaluating a T-cell-based assay for latent tuberculosis infection in healthcare workers in a general hospital in Beijing
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Interferon gamma in pleural fluid for diagnosing tuberculosis. A consecutive unselected series of 978 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 442s
Year: 2002
T-cell interferon-γ release assay for the diagnosis of tuberculous pleuritis in routine clinical practice
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease
Year: 2007
Significance of interferon gamma-inducible chemokines in pleural effusions
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
Source: Eur Respir J 2013; 41: 18-24
Year: 2013
False-negative interferon gamma release assay results in active tuberculosis: a TBNET study
Source: Eur Respir J 2015; 45: 279-283
Year: 2015
Routine DNA cytometry of pleural effusions: a prospective study
Source: Eur Respir J 2007; 30: Suppl. 51, 139s
Year: 2007
The value of interferon (IFN)-γ pleural effusion tests in diagnosis of tuberculosis
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Interferon gamma release assays based on M. tuberculosis-specific antigens (IGRAs) in sarcoidosis patients
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study
Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept